vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Thermon Group Holdings, Inc. (THR). Click either name above to swap in a different company.

Thermon Group Holdings, Inc. is the larger business by last-quarter revenue ($147.3M vs $104.5M, roughly 1.4× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 9.6%). Thermon Group Holdings, Inc. produced more free cash flow last quarter ($13.1M vs $-35.5M).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Thermon Group Holdings, Inc. is a global provider of engineered thermal management solutions, specializing in heat tracing systems, heating cables, temperature monitoring controls, and associated installation support services. It serves core industrial segments including oil and gas, chemical processing, power generation, and food and beverage, with operating bases across North America, Europe, Asia-Pacific, and Latin America.

IMCR vs THR — Head-to-Head

Bigger by revenue
THR
THR
1.4× larger
THR
$147.3M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+14.7% gap
IMCR
24.3%
9.6%
THR
More free cash flow
THR
THR
$48.6M more FCF
THR
$13.1M
$-35.5M
IMCR

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IMCR
IMCR
THR
THR
Revenue
$104.5M
$147.3M
Net Profit
$18.3M
Gross Margin
97.4%
46.6%
Operating Margin
-18.8%
18.1%
Net Margin
12.4%
Revenue YoY
24.3%
9.6%
Net Profit YoY
-1.3%
EPS (diluted)
$-0.61
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
THR
THR
Q4 25
$104.5M
$147.3M
Q3 25
$103.7M
$131.7M
Q2 25
$98.0M
$108.9M
Q1 25
$93.9M
Q4 24
$84.1M
Q3 24
$80.2M
Q2 24
$75.4M
Q1 24
$70.5M
Net Profit
IMCR
IMCR
THR
THR
Q4 25
$18.3M
Q3 25
$-177.0K
$15.0M
Q2 25
$-10.3M
$8.6M
Q1 25
$5.0M
Q4 24
Q3 24
$8.7M
Q2 24
$-11.6M
Q1 24
$-24.4M
Gross Margin
IMCR
IMCR
THR
THR
Q4 25
97.4%
46.6%
Q3 25
99.5%
46.4%
Q2 25
98.9%
44.1%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
THR
THR
Q4 25
-18.8%
18.1%
Q3 25
-6.9%
16.4%
Q2 25
-15.2%
10.8%
Q1 25
-3.9%
Q4 24
-23.1%
Q3 24
-10.6%
Q2 24
-21.2%
Q1 24
-37.6%
Net Margin
IMCR
IMCR
THR
THR
Q4 25
12.4%
Q3 25
-0.2%
11.4%
Q2 25
-10.5%
7.9%
Q1 25
5.4%
Q4 24
Q3 24
10.9%
Q2 24
-15.4%
Q1 24
-34.7%
EPS (diluted)
IMCR
IMCR
THR
THR
Q4 25
$-0.61
$0.55
Q3 25
$0.00
$0.45
Q2 25
$-0.20
$0.26
Q1 25
$0.10
Q4 24
$-0.47
Q3 24
$0.17
Q2 24
$-0.23
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
THR
THR
Cash + ST InvestmentsLiquidity on hand
$864.2M
$46.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$538.7M
Total Assets
$1.1B
$816.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
THR
THR
Q4 25
$864.2M
$46.9M
Q3 25
$892.4M
$29.7M
Q2 25
$882.8M
$36.5M
Q1 25
$837.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Q1 24
$832.8M
Total Debt
IMCR
IMCR
THR
THR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
THR
THR
Q4 25
$381.0M
$538.7M
Q3 25
$396.6M
$515.2M
Q2 25
$388.5M
$509.3M
Q1 25
$378.5M
Q4 24
$360.7M
Q3 24
$377.8M
Q2 24
$359.1M
Q1 24
$359.5M
Total Assets
IMCR
IMCR
THR
THR
Q4 25
$1.1B
$816.7M
Q3 25
$1.1B
$778.2M
Q2 25
$1.1B
$765.3M
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.1B
Q2 24
$1.0B
Q1 24
$994.0M
Debt / Equity
IMCR
IMCR
THR
THR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
THR
THR
Operating Cash FlowLast quarter
$-32.7M
$18.0M
Free Cash FlowOCF − Capex
$-35.5M
$13.1M
FCF MarginFCF / Revenue
-34.0%
8.9%
Capex IntensityCapex / Revenue
2.8%
3.3%
Cash ConversionOCF / Net Profit
0.98×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
THR
THR
Q4 25
$-32.7M
$18.0M
Q3 25
$-4.5M
$7.4M
Q2 25
$26.0M
$10.7M
Q1 25
$435.0K
Q4 24
$-14.0M
Q3 24
$21.1M
Q2 24
$23.5M
Q1 24
$-4.6M
Free Cash Flow
IMCR
IMCR
THR
THR
Q4 25
$-35.5M
$13.1M
Q3 25
$-5.2M
$4.4M
Q2 25
$25.6M
$8.3M
Q1 25
$137.0K
Q4 24
$-17.5M
Q3 24
$20.3M
Q2 24
$23.1M
Q1 24
$-5.0M
FCF Margin
IMCR
IMCR
THR
THR
Q4 25
-34.0%
8.9%
Q3 25
-5.0%
3.3%
Q2 25
26.1%
7.6%
Q1 25
0.1%
Q4 24
-20.9%
Q3 24
25.3%
Q2 24
30.7%
Q1 24
-7.1%
Capex Intensity
IMCR
IMCR
THR
THR
Q4 25
2.8%
3.3%
Q3 25
0.7%
2.3%
Q2 25
0.4%
2.2%
Q1 25
0.3%
Q4 24
4.3%
Q3 24
1.0%
Q2 24
0.4%
Q1 24
0.6%
Cash Conversion
IMCR
IMCR
THR
THR
Q4 25
0.98×
Q3 25
0.50×
Q2 25
1.25×
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

THR
THR

Other$73.7M50%
Transferred At Point In Time$56.1M38%
Transferred Over Time$17.5M12%

Related Comparisons